CREDIT: TEMPLE UNIVERSITY HEALTH SYSTEM (Philadelphia, PA) – The vast majority of cells in the human body contain tiny power plants known as mitochondria that generate much of the energy cells use for day-to-day activities. Like a dynamic renewable resource, these little power plants are constantly dividing and uniting in processes called fission and fusion....
by Georgia State University Foods, such as French fries, cheese, cookies, soda, and sports and energy drinks, are commonly found in the diets of United States adults with inflammatory bowel disease, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University. The researchers analyzed the National Health Interview...
Scientists were able to prevent obesity in mice by blocking macrohages, key inflammatory cells, within the body. Researchers from the Washington University School of Medicine in St. Louis have successfully disabled a gene in specific mouse cells, preventing mice from becoming obese even after being fed a high-fat diet. Macrophages, vital inflammatory cells which are...
by VIB (the Flanders Institute for Biotechnology) With a discovery that could rewrite the immunology textbooks, an international group of scientists, including the teams of Bart Lambrecht, Martin Guilliams, Hamida Hammad, and Charlotte Scott (all from the VIB-UGent Center for Inflammation Research) identified a new type of antigen-presenting immune cell. These cells, that are part...
By SAM BLANCHARD SENIOR HEALTH REPORTER FOR MAILONLINE and STEPHEN MATTHEWS HEALTH EDITOR FOR MAILONLINE he illness is similar to COVID-19, doctors say, but some children test negative Children with the condition have been found to have swelling in their hearts Young people have been largely unaffected during the coronavirus pandemic Here’s how to help...
By Tiziana Celine Tech Times Doctors are hoping stem cell therapy may be a weapon in the fight against coronavirus. Regenerative medicine employer Mesoblast introduced a 300-person trial on Friday, Apr. 24, to decide whether or not stem cell treatments will work in COVID-19 patients tormented by severe lung inflammation. The treatments had been intravenous...
by The Scripps Research Institute An anti-inflammatory drug developed at Scripps Research 25 years ago is now being tested as a way to prevent acute respiratory distress in patients with COVID-19, the pandemic disease caused by the novel coronavirus. The drug, a monoclonal antibody now owned by the pharmaceutical company Implicit Bioscience, is planned to...
by E.j. Mundell, Healthday Reporter For many COVID-19 patients battling for their lives in the ICU, a runaway immune system response—known as a “cytokine storm”—is their primary foe. Doctors have few tools to help tame this hyperinflammatory condition, but early research is suggesting that nanotechnology might safely deliver drugs to affected tissues, quieting the storm....
By Nick Lavars Inflammation is a major focus of much medical research, with its links to arthritis, liver disease, cancers and many more illnesses. A new study carried out at Australia’s Peter Mac Cancer Centre has provided a possible new pathway forward, revealing that drugs under development to treat cancer could be used to temper...
Autologous Mesenchymal Stem Cells to Provide Immune Support Against COVID-19 HOUSTON, April 6, 2020 — Hope Biosciences, a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic disease, today announced that FDA has approved a Phase II clinical trial evaluating efficacy and safety of Hope Biosciences’ autologous, adipose-derived mesenchymal stem cells...
